Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05455359
PHASE4

Gastrointestinal Dysmotility on Aspiration Risk

Sponsor: Boston Children's Hospital

View on ClinicalTrials.gov

Summary

The hypothesis of this study is that esophageal and gastric dysmotility increase the risk of developing aspiration-associated symptoms in children with neurologic impairment. The investigators are conducting a ten week cross over study comparing prucalopride to famotidine for the treatment of aspiration-associated symptoms.

Official title: The Impact of Upper Gastrointestinal Dysmotility on Aspiration-associated Symptoms

Key Details

Gender

All

Age Range

5 Years - 21 Years

Study Type

INTERVENTIONAL

Enrollment

120

Start Date

2025-02-13

Completion Date

2027-05-31

Last Updated

2025-12-26

Healthy Volunteers

No

Interventions

DRUG

Prucalopride

Prucalopride 0.04 mg/kg/day

DRUG

Famotidine

Famotidine 0.4 mg/kg/day

Locations (1)

Boston Children's Hospital

Boston, Massachusetts, United States